LAZZARICH, Elisa
 Distribuzione geografica
Continente #
NA - Nord America 338
EU - Europa 282
AS - Asia 227
SA - Sud America 44
AF - Africa 2
Totale 893
Nazione #
US - Stati Uniti d'America 328
IE - Irlanda 91
HK - Hong Kong 85
DE - Germania 57
SG - Singapore 55
SE - Svezia 50
CN - Cina 42
BR - Brasile 37
UA - Ucraina 33
RU - Federazione Russa 18
VN - Vietnam 17
IN - India 16
FI - Finlandia 12
GB - Regno Unito 9
CA - Canada 7
IR - Iran 5
IT - Italia 5
AR - Argentina 3
NL - Olanda 3
AE - Emirati Arabi Uniti 2
FR - Francia 2
ID - Indonesia 2
MX - Messico 2
TR - Turchia 2
CL - Cile 1
DZ - Algeria 1
EC - Ecuador 1
JP - Giappone 1
LV - Lettonia 1
PA - Panama 1
PE - Perù 1
PL - Polonia 1
PY - Paraguay 1
ZA - Sudafrica 1
Totale 893
Città #
Dublin 90
Hong Kong 85
Jacksonville 66
Wilmington 25
Beijing 24
Dearborn 19
Ashburn 18
Singapore 14
Los Angeles 13
Dallas 12
Bremen 11
Lawrence 11
Princeton 11
San Mateo 9
Moscow 8
Ann Arbor 6
Ho Chi Minh City 6
Chandler 5
New York 5
Orem 4
Poplar 4
São Paulo 4
Buffalo 3
Denver 3
Glasgow 3
Redondo Beach 3
Toronto 3
Zanjan 3
Ankara 2
Atlanta 2
Chicago 2
Fairfield 2
Guarulhos 2
Hanoi 2
Jakarta 2
Mexico City 2
Montreal 2
Munich 2
New Delhi 2
Novara 2
Phoenix 2
Salvador 2
Santa Clara 2
Stockholm 2
Alfenas 1
Amsterdam 1
Annapolis 1
Araçatuba 1
Ardabil 1
Asunción 1
Augusta 1
Balneário Arroio do Silva 1
Batna City 1
Berazategui 1
Biên Hòa 1
Brasília 1
Brumadinho 1
Camaçari 1
Campinas 1
Canoas 1
Catanduva 1
Chennai 1
Cleveland 1
Cotia 1
Da Nang 1
Dubai 1
Espoo 1
Fuzhou 1
Goiânia 1
Guangzhou 1
Iracemápolis 1
Jinan 1
Johannesburg 1
Kunming 1
Libertad 1
Lima 1
Lấp Vò 1
Maceió 1
Miami 1
Milan 1
Monmouth Junction 1
Montes Claros 1
Nanjing 1
Nichelino 1
Niquelândia 1
Norwalk 1
Nossa Senhora da Glória 1
Oklahoma City 1
Orlando 1
Panama City 1
Paraibuna 1
Patrocínio Paulista 1
Phủ Lý 1
Porteiras 1
Quilmes 1
Quzhou 1
Quảng Ngãi 1
Registro 1
Rolim de Moura 1
Roubaix 1
Totale 556
Nome #
Prophylactic perioperative plasmapheresis does not prevent rebound of permeability factors in patients with focal segmental glomerulosclerosis (FSGS) who undergo kidney transplant. 109
Unexpectedly high prevalence of rare genetic disorders in kidney transplant recipients with an unknown causal nephropathy. 93
Warning: standard doses of low molecular weight heparin exceed the upper threshold of the anti-Xa range according to the degree of renal failure. 92
Clinical hypothesis predicts renal pathology in 67% of renal diseases: a 30-year experience on 1288 renal biopsies. 88
Anti-phospholipid nephropathy only belongs to Myakis I and IIA classes, always in association with lupus anticoagulant, but never anti-b(2)GP1 antibodies. 87
Risk factors for kidney graft loss: the role of HCV infection in 400 consecutive cases. 82
MGUS in renal transplant: still a matter of conern? 79
Why have outcomes of lupus nephritis been improving over the last 40 years? A monocentric experience. 73
Is plamapheresis effective to prevent FSGS recurrence on transplanted kidney? 73
Unexpectedly high prevalence of critic coronary artery disease in asymptomatic dialysis patients screened for transplant wait list. 64
Conversion to rapamycin in renal transplanted patients who develop cancer: preliminary observation on a monocentric experience. 64
Totale 904
Categoria #
all - tutte 4.631
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.631


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202134 0 0 0 0 0 0 11 0 11 1 11 0
2021/202258 3 1 8 4 6 0 0 2 4 3 14 13
2022/2023190 13 8 15 0 12 12 0 14 99 0 12 5
2023/2024126 5 7 6 2 11 0 64 1 0 0 21 9
2024/202572 1 0 3 3 11 2 0 11 18 11 1 11
2025/2026227 24 9 39 102 51 2 0 0 0 0 0 0
Totale 904